Company news
Aptose Biosciences Inc news in 2015
Aptose Biosciences Inc's news releases, calls and decks from 2015, newest first.
Aptose Biosciences announces results of annual and special meeting of shareholders
June 10, 2015
Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia
June 2, 2015
Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015
May 5, 2015
Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and Webcast
April 30, 2015
Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board
March 23, 2015
Aptose Biosciences to Present at the 12th Annual BIO Asia International Conference
March 23, 2015
Aptose Biosciences to Present at the 27th Annual ROTH Conference
March 5, 2015
Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014
March 3, 2015
Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and Webcast
February 26, 2015
Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare Conference
February 25, 2015
Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare Conference
February 19, 2015
Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee
January 20, 2015
Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies
January 13, 2015
Aptose Biosciences to Present at Biotech Showcase(TM) 2015
January 12, 2015